The arrhythmia monitoring devices market size has grown rapidly in recent years. It will grow from $8.16 billion in 2025 to $9.02 billion in 2026 at a compound annual growth rate (CAGR) of 10.5%. The growth in the historic period can be attributed to rising prevalence of cardiovascular diseases, increased use of ECG-based diagnostics, expansion of cardiac care facilities, growing awareness of arrhythmia-related risks, availability of portable monitoring devices.
The arrhythmia monitoring devices market size is expected to see strong growth in the next few years. It will grow to $13.15 billion in 2030 at a compound annual growth rate (CAGR) of 9.9%. The growth in the forecast period can be attributed to increasing adoption of remote patient monitoring, rising demand for continuous real-time cardiac data, expansion of home-based cardiac diagnostics, growing integration of ai-driven analytics, increasing focus on preventive cardiology. Major trends in the forecast period include increasing adoption of remote cardiac monitoring solutions, rising use of wearable arrhythmia detection devices, growing integration of ai-based rhythm analysis, expansion of long-term continuous monitoring systems, enhanced focus on early arrhythmia diagnosis.
The growth of the arrhythmia monitoring devices market is being fueled by the increasing incidence of cardiovascular diseases. These diseases, which affect the heart and blood vessels, require monitoring devices to detect irregular heart rates, a primary symptom in most cases. For instance, in January 2024, according to the American Heart Association, a US-based non-profit organization, the age-adjusted death rate from cardiovascular disease increased to 233.3 per 100,000 in 2024 up 4% from 224.4 per 100,000 in 2023. This uptrend in cardiovascular diseases is expected to drive the demand for arrhythmia monitoring devices.
Technological advancements represent a significant trend in the arrhythmia monitoring devices market. Leading companies in this sector are incorporating innovative technologies such as AI and detection systems to enhance accuracy and efficiently manage data. For example, in September 2024, iRhythm Technologies, a US-based digital healthcare company, announced that the Zio ECG Monitoring System received Japanese Regulatory Approval. The Zio system signifies a substantial improvement in cardiac arrhythmia diagnostics compared to traditional Holter monitoring, providing greater clinical accuracy to aid physicians in making precise diagnoses from the outset. iRhythm's deep learning technology can accurately classify a broad spectrum of distinct arrhythmias, achieving diagnostic performance comparable to that of cardiologists. In clinical settings, this service has the potential to decrease the occurrence of misdiagnosed computerized ECG interpretations and improve overall clinical efficiency.
In May 2024, WearLinq, a US-based digital healthcare solutions provider, acquired AMI Cardiac Monitoring for an undisclosed sum. This acquisition enables the company to offer comprehensive clinical services across the nation, thereby increasing access to its eWave six-lead wearable ECG monitor, which has recently obtained 510(k) clearance from the U.S. Food and Drug Administration (FDA). AMI Cardiac Monitoring is a US-based manufacturer of ECG devices.
Major companies operating in the arrhythmia monitoring devices market are Abbott Laboratories, Medtronic plc, Biotronik Inc., iRhythm Technologies Inc., GE HealthCare Technologies Inc., Koninklijke Philips NV, ACS Diagnostics Inc., AliveCor Inc., Medi-Lynx Cardiac Monitoring LLC, Spacelabs Healthcare Inc., Fukuda Denshi Co. Ltd., Applied Cardiac Systems Inc., BIOTRONIK SE & Co. KG, Nihon Kohden Corporation, CardioNet LLC, Bardy Diagnostics Inc., BioTelemetry Inc., Boston Scientific Corporation, CardioComm Solutions Inc., Cardiac Insight Inc., Cardiac Science Corporation, Johnson & Johnson, Preventice Solutions Inc., Qardio Inc., ZOLL Medical Corporation.
North America was the largest region in the arrhythmia monitoring devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the arrhythmia monitoring devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the arrhythmia monitoring devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the arrhythmia monitoring devices market by increasing costs of imported sensors, microelectronics, wireless modules, and diagnostic components used in ECG systems, implantable monitors, and telemetry devices. Healthcare providers in North America and Europe are most affected due to reliance on imported medical electronics, while Asia-Pacific faces higher production costs for export-oriented devices. These tariffs are increasing device prices and procurement costs. However, they are also driving local manufacturing, regional sourcing of components, and innovation in cost-efficient cardiac monitoring solutions.
The arrhythmia monitoring devices market research report is one of a series of new reports that provides arrhythmia monitoring devices market statistics, including arrhythmia monitoring devices industry global market size, regional shares, competitors with a arrhythmia monitoring devices market share, detailed arrhythmia monitoring devices market segments, market trends and opportunities, and any further data you may need to thrive in the arrhythmia monitoring devices industry. This arrhythmia monitoring devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Arrhythmia monitoring devices play a crucial role in identifying and determining the type and cause of abnormal heart rhythms. These devices are utilized for tracking and monitoring irregular heart rhythms associated with arrhythmia, a heart condition that disrupts the pace or rhythm of the heartbeat.
The primary types of arrhythmia monitoring devices include ECG (Electrocardiogram), implantable monitors, holter monitors, and mobile cardiac telemetry. ECG is particularly effective in detecting electrical impulses generated by the heart, providing valuable insights for diagnosing various cardiac issues. Arrhythmia monitoring devices find applications in diverse cardiac conditions, including bradycardia, tachycardia, atrial fibrillation, ventricular fibrillation, premature contraction, and other related applications. These devices cater to various end-users, including hospitals and diagnostic centers, ambulatory centers, and other healthcare facilities, playing a crucial role in monitoring and managing heart-related conditions.
The arrhythmia monitoring devices market consists of sales of cardiac event monitors, loop memory monitor, patch recorder, and symptom event monitor. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The arrhythmia monitoring devices market size is expected to see strong growth in the next few years. It will grow to $13.15 billion in 2030 at a compound annual growth rate (CAGR) of 9.9%. The growth in the forecast period can be attributed to increasing adoption of remote patient monitoring, rising demand for continuous real-time cardiac data, expansion of home-based cardiac diagnostics, growing integration of ai-driven analytics, increasing focus on preventive cardiology. Major trends in the forecast period include increasing adoption of remote cardiac monitoring solutions, rising use of wearable arrhythmia detection devices, growing integration of ai-based rhythm analysis, expansion of long-term continuous monitoring systems, enhanced focus on early arrhythmia diagnosis.
The growth of the arrhythmia monitoring devices market is being fueled by the increasing incidence of cardiovascular diseases. These diseases, which affect the heart and blood vessels, require monitoring devices to detect irregular heart rates, a primary symptom in most cases. For instance, in January 2024, according to the American Heart Association, a US-based non-profit organization, the age-adjusted death rate from cardiovascular disease increased to 233.3 per 100,000 in 2024 up 4% from 224.4 per 100,000 in 2023. This uptrend in cardiovascular diseases is expected to drive the demand for arrhythmia monitoring devices.
Technological advancements represent a significant trend in the arrhythmia monitoring devices market. Leading companies in this sector are incorporating innovative technologies such as AI and detection systems to enhance accuracy and efficiently manage data. For example, in September 2024, iRhythm Technologies, a US-based digital healthcare company, announced that the Zio ECG Monitoring System received Japanese Regulatory Approval. The Zio system signifies a substantial improvement in cardiac arrhythmia diagnostics compared to traditional Holter monitoring, providing greater clinical accuracy to aid physicians in making precise diagnoses from the outset. iRhythm's deep learning technology can accurately classify a broad spectrum of distinct arrhythmias, achieving diagnostic performance comparable to that of cardiologists. In clinical settings, this service has the potential to decrease the occurrence of misdiagnosed computerized ECG interpretations and improve overall clinical efficiency.
In May 2024, WearLinq, a US-based digital healthcare solutions provider, acquired AMI Cardiac Monitoring for an undisclosed sum. This acquisition enables the company to offer comprehensive clinical services across the nation, thereby increasing access to its eWave six-lead wearable ECG monitor, which has recently obtained 510(k) clearance from the U.S. Food and Drug Administration (FDA). AMI Cardiac Monitoring is a US-based manufacturer of ECG devices.
Major companies operating in the arrhythmia monitoring devices market are Abbott Laboratories, Medtronic plc, Biotronik Inc., iRhythm Technologies Inc., GE HealthCare Technologies Inc., Koninklijke Philips NV, ACS Diagnostics Inc., AliveCor Inc., Medi-Lynx Cardiac Monitoring LLC, Spacelabs Healthcare Inc., Fukuda Denshi Co. Ltd., Applied Cardiac Systems Inc., BIOTRONIK SE & Co. KG, Nihon Kohden Corporation, CardioNet LLC, Bardy Diagnostics Inc., BioTelemetry Inc., Boston Scientific Corporation, CardioComm Solutions Inc., Cardiac Insight Inc., Cardiac Science Corporation, Johnson & Johnson, Preventice Solutions Inc., Qardio Inc., ZOLL Medical Corporation.
North America was the largest region in the arrhythmia monitoring devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the arrhythmia monitoring devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the arrhythmia monitoring devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the arrhythmia monitoring devices market by increasing costs of imported sensors, microelectronics, wireless modules, and diagnostic components used in ECG systems, implantable monitors, and telemetry devices. Healthcare providers in North America and Europe are most affected due to reliance on imported medical electronics, while Asia-Pacific faces higher production costs for export-oriented devices. These tariffs are increasing device prices and procurement costs. However, they are also driving local manufacturing, regional sourcing of components, and innovation in cost-efficient cardiac monitoring solutions.
The arrhythmia monitoring devices market research report is one of a series of new reports that provides arrhythmia monitoring devices market statistics, including arrhythmia monitoring devices industry global market size, regional shares, competitors with a arrhythmia monitoring devices market share, detailed arrhythmia monitoring devices market segments, market trends and opportunities, and any further data you may need to thrive in the arrhythmia monitoring devices industry. This arrhythmia monitoring devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Arrhythmia monitoring devices play a crucial role in identifying and determining the type and cause of abnormal heart rhythms. These devices are utilized for tracking and monitoring irregular heart rhythms associated with arrhythmia, a heart condition that disrupts the pace or rhythm of the heartbeat.
The primary types of arrhythmia monitoring devices include ECG (Electrocardiogram), implantable monitors, holter monitors, and mobile cardiac telemetry. ECG is particularly effective in detecting electrical impulses generated by the heart, providing valuable insights for diagnosing various cardiac issues. Arrhythmia monitoring devices find applications in diverse cardiac conditions, including bradycardia, tachycardia, atrial fibrillation, ventricular fibrillation, premature contraction, and other related applications. These devices cater to various end-users, including hospitals and diagnostic centers, ambulatory centers, and other healthcare facilities, playing a crucial role in monitoring and managing heart-related conditions.
The arrhythmia monitoring devices market consists of sales of cardiac event monitors, loop memory monitor, patch recorder, and symptom event monitor. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Arrhythmia Monitoring Devices Market Characteristics
3. Arrhythmia Monitoring Devices Market Supply Chain Analysis
4. Global Arrhythmia Monitoring Devices Market Trends and Strategies
5. Arrhythmia Monitoring Devices Market Analysis of End Use Industries
7. Global Arrhythmia Monitoring Devices Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Arrhythmia Monitoring Devices Total Addressable Market (TAM) Analysis for the Market
9. Arrhythmia Monitoring Devices Market Segmentation
10. Arrhythmia Monitoring Devices Market Regional and Country Analysis
11. Asia-Pacific Arrhythmia Monitoring Devices Market
12. China Arrhythmia Monitoring Devices Market
13. India Arrhythmia Monitoring Devices Market
14. Japan Arrhythmia Monitoring Devices Market
15. Australia Arrhythmia Monitoring Devices Market
16. Indonesia Arrhythmia Monitoring Devices Market
17. South Korea Arrhythmia Monitoring Devices Market
18. Taiwan Arrhythmia Monitoring Devices Market
19. South East Asia Arrhythmia Monitoring Devices Market
20. Western Europe Arrhythmia Monitoring Devices Market
21. UK Arrhythmia Monitoring Devices Market
22. Germany Arrhythmia Monitoring Devices Market
23. France Arrhythmia Monitoring Devices Market
24. Italy Arrhythmia Monitoring Devices Market
25. Spain Arrhythmia Monitoring Devices Market
26. Eastern Europe Arrhythmia Monitoring Devices Market
27. Russia Arrhythmia Monitoring Devices Market
28. North America Arrhythmia Monitoring Devices Market
29. USA Arrhythmia Monitoring Devices Market
30. Canada Arrhythmia Monitoring Devices Market
31. South America Arrhythmia Monitoring Devices Market
32. Brazil Arrhythmia Monitoring Devices Market
33. Middle East Arrhythmia Monitoring Devices Market
34. Africa Arrhythmia Monitoring Devices Market
36. Arrhythmia Monitoring Devices Market Competitive Landscape and Company Profiles
37. Arrhythmia Monitoring Devices Market Other Major and Innovative Companies
40. Arrhythmia Monitoring Devices Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Arrhythmia Monitoring Devices Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses arrhythmia monitoring devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for arrhythmia monitoring devices? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The arrhythmia monitoring devices market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Type: ECG; Implantable Monitors; Holter Monitors; Mobile Cardiac Telemetry2) By Application: Bradycardia; Tachycardia; Atrial Fibrillation; Ventricular Fibrillation; Premature Contraction; Other Applications
3) By End-User: Hospitals And Diagnostic Centers; Ambulatory Centers
Subsegments:
1) By ECG (Electrocardiogram): Resting ECG Machines; Stress ECG Machines; 12-Lead ECG Systems2) By Implantable Monitors: Implantable Loop Recorders (ILRs); Subcutaneous Implantable Cardioverter Defibrillators (S-ICDs)
3) By Holter Monitors: 24-Hour Holter Monitors; 48-Hour Holter Monitors; 7-Day Holter Monitors
4) By Mobile Cardiac Telemetry: Wireless Telemetry Devices; Smartphone-Integrated Telemetry Systems
Companies Mentioned: Abbott Laboratories; Medtronic plc; Biotronik Inc.; iRhythm Technologies Inc.; GE HealthCare Technologies Inc.; Koninklijke Philips NV; ACS Diagnostics Inc.; AliveCor Inc.; Medi-Lynx Cardiac Monitoring LLC; Spacelabs Healthcare Inc.; Fukuda Denshi Co. Ltd.; Applied Cardiac Systems Inc.; BIOTRONIK SE & Co. KG; Nihon Kohden Corporation; CardioNet LLC; Bardy Diagnostics Inc.; BioTelemetry Inc.; Boston Scientific Corporation; CardioComm Solutions Inc.; Cardiac Insight Inc.; Cardiac Science Corporation; Johnson & Johnson; Preventice Solutions Inc.; Qardio Inc.; ZOLL Medical Corporation
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Arrhythmia Monitoring Devices market report include:- Abbott Laboratories
- Medtronic plc
- Biotronik Inc.
- iRhythm Technologies Inc.
- GE HealthCare Technologies Inc.
- Koninklijke Philips NV
- ACS Diagnostics Inc.
- AliveCor Inc.
- Medi-Lynx Cardiac Monitoring LLC
- Spacelabs Healthcare Inc.
- Fukuda Denshi Co. Ltd.
- Applied Cardiac Systems Inc.
- BIOTRONIK SE & Co. KG
- Nihon Kohden Corporation
- CardioNet LLC
- Bardy Diagnostics Inc.
- BioTelemetry Inc.
- Boston Scientific Corporation
- CardioComm Solutions Inc.
- Cardiac Insight Inc.
- Cardiac Science Corporation
- Johnson & Johnson
- Preventice Solutions Inc.
- Qardio Inc.
- ZOLL Medical Corporation
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 9.02 Billion |
| Forecasted Market Value ( USD | $ 13.15 Billion |
| Compound Annual Growth Rate | 9.9% |
| Regions Covered | Global |
| No. of Companies Mentioned | 26 |
